Cabergoline versus levodopa monotherapy

2004 ◽  
Vol 19 (6) ◽  
pp. 733-734
Author(s):  
Keith Wheatley ◽  
Carl E. Clarke ◽  
Natalie Ives ◽  
Richard Gray
Keyword(s):  
Levodopa Monotherapy

Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study

2005 ◽  
Vol 21 (3) ◽  
pp. 343-353 ◽  
Author(s):  
Wolfgang H. Oertel ◽  
Erik Wolters ◽  
Cristina Sampaio ◽  
Santiago Gimenez-Roldan ◽  
Bruno Bergamasco ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Early Parkinson’S Disease ◽  
Levodopa Monotherapy

scholarly journals Efficacy and safety of combination therapy with pramipexole and levodopa vs levodopa monotherapy in patients with Parkinson disease

Medicine ◽  
2021 ◽  
Vol 100 (44) ◽  
pp. e27511
Author(s):  
Yan Wang ◽  
De-Qi Jiang ◽  
Cheng-Shu Lu ◽  
Ming-Xing Li ◽  
Li-Lin Jiang
Keyword(s):  
Combination Therapy ◽  
Parkinson Disease ◽  
Efficacy And Safety ◽  
Levodopa Monotherapy

Rasagiline combined with levodopa therapy versus levodopa monotherapy for patients with Parkinson’s disease: a systematic review

2019 ◽  
Vol 41 (1) ◽  
pp. 101-109 ◽  
Author(s):  
De-Qi Jiang ◽  
Hua-Kun Wang ◽  
Yan Wang ◽  
Ming-Xing Li ◽  
Li-Lin Jiang ◽  
...  
Keyword(s):  
Systematic Review ◽  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Levodopa Therapy ◽  
Levodopa Monotherapy

Dilemma in Parkinson’s Treatment; Levodopa Monotherapy May be the Best Choice

2020 ◽  
Vol 79 ◽  
pp. 219-223
Author(s):  
Mohammad Hossein Abbasi ◽  
Sara Esmaeili ◽  
Seyed Amirhassan Habibi ◽  
Gholam Ali Shahidi
Keyword(s):  
Levodopa Monotherapy

scholarly journals National Trends of Antiparkinsonism Treatment in Taiwan: 2004–2011

2016 ◽  
Vol 2016 ◽  
pp. 1-8 ◽  
Author(s):  
Weng-Ming Liu ◽  
Ruey-Meei Wu ◽  
Chia-Hsuin Chang ◽  
Jou-Wei Lin ◽  
Ying-Chun Liu ◽  
...  
Keyword(s):  
Combination Therapy ◽  
Temporal Trends ◽  
Aged Patients ◽  
Increasing Trend ◽  
Increase Rate ◽  
Taiwan National Health Insurance ◽  
Major Treatment ◽  
National Trends ◽  
Insurance Database ◽  
Levodopa Monotherapy

Background. Several guidelines for Parkinson’s disease (PD) management were recently updated. We examined temporal trends for antiparkinsonism drugs in Taiwan.Methods. Antiparkinsonism prescriptions, including levodopa, ergot/nonergot dopamine agonists (DAs), amantadine, selegiline, entacapone, and anticholinergics, were identified in the Taiwan National Health Insurance Database from 2004 to 2011. Time trend analyses were estimated assuming Poisson distribution.Results. A total of 19,302 PD patients in 2004 and 41,606 PD patients in 2011 were analyzed. Antiparkinsonism prescriptions increased significantly from 187,137 in 2004 to 414,587 in 2011. Levodopa monotherapy or combination therapy was the mainstay. Levodopa monotherapy comprised 37.4% of prescriptions in 2004 and 44.2% in 2011, with an annual increase rate of 18.14%. There was a substantially increasing trend of DA prescriptions, which were higher in younger-aged patients (<60 years) than in older-aged group (p=0.0006). Among combination therapy, DA combined with levodopa or other antiparkinsonism medications became the main combinations for younger-aged patients after 2009. After 2005, the proportion of ergot DA usage markedly decreased and PD patients using nonergot DA increased.Conclusions. Levodopa was the major treatment from 2004 to 2011. There was a steeply increased trend of DA use, especially in younger-aged patients. Nonergot agents comprised the major DA group after 2005.

Five-Year Follow-Up of Early Lisuride and Levodopa Combination Therapy versus Levodopa Monotherapy in de novo Parkinson’s Disease

2000 ◽  
Vol 44 (1) ◽  
pp. 22-30 ◽  
Author(s):  
H. Allain ◽  
A. Destée ◽  
H. Petit ◽  
M. Patay ◽  
S. Schück ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Combination Therapy ◽  
De Novo ◽  
Levodopa Monotherapy

Levodopa monotherapy can induce "sleep attacks" in Parkinson's disease patients

2001 ◽  
Vol 248 (5) ◽  
pp. 426-427 ◽  
Author(s):  
Joaquim J. Ferreira ◽  
Claire Thalamas ◽  
Jean Louis Montastruc ◽  
Alexandre Castro-Caldas ◽  
Olivier Rascol
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Levodopa Monotherapy
Sign in / Sign up

Export Citation Format

Share Document